Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13–18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prediabetes has been found to be associated with decreased heart rate variability61 (HRV – a marker of parasympathetic function),62–65, decreased postural changes in heart rate,62 increased prevalence of erectile dysfunction among men,66 and a worse profile in tests of sympathetic and parasympathetic function.67”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in prediabetes and sensorimotor neuropathy 68–70 suggest that IGT and early diabetic neuropathy may involve small demyelinated fibres.61”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Diabetic neuropathy (distal symmetric polyneuropathy (DSPN)) causes bilateral decrease or loss of ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“These criteria include obvious bilateral loss or reduction of the ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“No consistent evidence is available to suggest that prediabetes is associated with measurements of orthostatic blood pressure changes,63 which is a late marker of diabetic neuropathy,61 or with decreased expiratory-inspiratory ratio or change in heart rate during breathing.63”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationDyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482 · cited 3×
“The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy (DSPN) and is thought to be the most common variety (1).”
BackgroundSelf-citationVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationDiabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255 · cited 3×
“Some pathogenetic mechanisms may link CAN to cardiovascular dysfunction and diabetic complications (34).”
BackgroundInfluentialSelf-citationGæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913 · cited 3×
“The symptoms are distal, symmetrical, often associated with nocturnal exacerbations, and commonly described as prickling, deep aching, sharp, like an electric shock, and burning (13) with hyperalgesia and frequently allodynia upon examination (17).”
BackgroundInfluentialSelf-citationLauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Self-citationSima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Self-citation
Research works printed but not linked: 1
- Appell, 1991, DM and Other Peripheral Neuropathies Affecting Lower Urinary Tract Function, 365
Cited by
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
Self-citationColloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R., Truini, A., Attal, N., Finnerup, N. B., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.2 · Cited by 2,058
Self-citationFeldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0092-1 · Cited by 1,697
Spallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957
“CAN is defined as the impairment of autonomic control of the cardiovascular system in the setting of diabetes after exclusion of other causes [6].”
BackgroundSelf-citationHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Self-citationAdvances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy
Tesfaye, S., & Selvarajah, D. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2239 · Cited by 615
“An abnormality of nerve conduction tests, which is frequently subclinical, appears to be the first objective quantitative indication of the condition’ [4].”
BackgroundSelf-citationTreatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline
LeRoith, D., Biessels, G. J., Braithwaite, S. S., Casanueva, F. F., Draznin, B., Halter, J. B., Hirsch, I. B., McDonnell, M. E., Molitch, M. E., Murad, M. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00198 · Cited by 568
Microvascular Complications of Type 2 Diabetes Mellitus
Faselis, C., Katsimardou, A., Imprialos, K., Deligkaris, P., Kallistratos, M., & Dimitriadis, K. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161117666190502103733 · Cited by 549
Prediabetes diagnosis and treatment: A review
Bansal, N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.296 · Cited by 579
Diabetic neuropathy: cellular mechanisms as therapeutic targets
Vincent, A. M., Callaghan, B. C., Smith, A. L., & Feldman, E. L. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.137 · Cited by 566
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Self-citationDiabetes in sub-Saharan Africa: from clinical care to health policy
Atun, R., Davies, J. I., Gale, E. A. M., Bärnighausen, T., Beran, D., Kengne, A. P., Levitt, N. S., Mangugu, F. W., Nyirenda, M. J., Ogle, G. D., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30181-x · Cited by 543
Self-citationGain of function Na V 1.7 mutations in idiopathic small fiber neuropathy
Faber, C. G., Hoeijmakers, J. G. J., Ahn, H., Cheng, X., Han, C., Choi, J., Estacion, M., Lauria, G., Vanhoutte, E. K., Gerrits, M. M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22485 · Cited by 557
Self-citationPathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
“Adapted with permission from ref.(18), ADA.”
Self-citationDiabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
“482 Some studies have reported high oxidative status and oxidative stress index together with 483 low serum total antioxidant status in serum from DPN patients (87).”
BackgroundInfluentialSelf-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Dyck, P. J., Albers, J. W., Andersen, H., Arezzo, J. C., Biessels, G., Bril, V., Feldman, E. L., Litchy, W. J., O'Brien, P. C., Russell, J. W., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1226 · Cited by 497
Self-citationMartin, C. L., Albers, J. W., Pop-Busui, R., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2114 · Cited by 499
Herman, W. H., Pop‐Busui, R., Braffett, B. H., Martin, C. L., Cleary, P. A., Albers, J. W., Feldman, E. L., & The DCCT/EDIC Research Group (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03644.x · Cited by 493
Comorbidities of Diabetes and Hypertension: Mechanisms and Approach to Target Organ Protection
Long, A. N., & Dagogo‐Jack, S. (2011) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00434.x · Cited by 491
Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy
Iqbal, Z., Azmi, S., Yadav, R., Ferdousi, M., Kumar, M., Cuthbertson, D. J., Lim, J., Malik, R. A., & Alam, U. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.04.001 · Cited by 487
Self-citationMicrovascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease
Horton, W. B., & Barrett, E. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa025 · Cited by 424
Vascular Complications of Diabetes
Beckman, J. A., & Creager, M. A. (2016) · Circulation Research · doi:10.1161/circresaha.115.306884 · Cited by 412
Tesfaye, S., Vileikyte, L., Rayman, G., Sindrup, S. H., Perkins, B. A., Baconja, M., Vinik, A. I., Boulton, A. J. M., & Neuropathy, O. B. O. T. T. E. P. O. D. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1225 · Cited by 410
“Although a summarized version of this review has recently been published [1], this”
BackgroundSelf-citationDiabetic peripheral neuropathy: Current perspective and future directions
Singh, R., Kishore, L., & Kaur, N. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.12.005 · Cited by 400
Chow, E., Bernjak, A., Williams, S., Fawdry, R. A., Hibbert, S., Freeman, J., Sheridan, P. J., & Heller, S. R. (2014) · Diabetes · doi:10.2337/db13-0468 · Cited by 403
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease
Vinik, A. I., Erbas, T., & Casellini, C. M. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12042 · Cited by 371
Self-citationVinik, A. I., Nevoret, M.-L., Casellini, C., & Parson, H. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.06.001 · Cited by 366
Self-citationDiabetic Neuropathy: Mechanisms, Emerging Treatments, and Subtypes
Albers, J. W., & Pop-Busui, R. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0473-5 · Cited by 357
Cardiac autonomic neuropathy in patients with diabetes mellitus
Dimitropoulos, G. (2014) · World J Diabetes · doi:10.4239/wjd.v5.i1.17 · Cited by 357
Autonomic Nervous System Dysfunction
Goldberger, J. J., Arora, R., Buckley, U., & Shivkumar, K. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.064 · Cited by 337
Mechanisms and Management of Diabetic Painful Distal Symmetrical Polyneuropathy
Tesfaye, S., Boulton, A. J. M., & Dickenson, A. H. (2013) · Diabetes Care · doi:10.2337/dc12-1964 · Cited by 348
Self-citationChallenges of neuropathic pain: focus on diabetic neuropathy
Rosenberger, D. C., Blechschmidt, V., Timmerman, H., Wolff, A., & Treede, R.-D. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02145-7 · Cited by 325
“While up to 60% in patients with chronic DM are affected by dPNP, already in newly diagnosed patients, 7–10% suffer from neuropathy (Tracy and Dyck 2008; Tesfaye 2010; Abbott 2011).”
BackgroundThe diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes
Terkelsen, A. J., Karlsson, P., Lauria, G., Freeman, R., Finnerup, N. B., & Jensen, T. S. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30329-0 · Cited by 330
Self-citationThemistocleous, A. C., Ramirez, J. D., Shillo, P. R., Lees, J. G., Selvarajah, D., Orengo, C., Tesfaye, S., Rice, A. S. C., & Bennett, D. L. H. (2016) · Pain · doi:10.1097/j.pain.0000000000000491 · Cited by 313
Self-citationSudoscan, a Noninvasive Tool for Detecting Diabetic Small Fiber Neuropathy and Autonomic Dysfunction
Casellini, C. M., Parson, H. K., Richardson, M. S., Nevoret, M. L., & Vinik, A. I. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0129 · Cited by 322
“The study population consisted of 83 patients with type 1 or 2 DM with and without DPN, diagnosed using the current Toronto classification of DPN.(1) Diabetes patients were compared with a database of 210 healthy controls (HCs) provided by Impeto Medical.”
BackgroundMethodInfluentialSelf-citation(2013) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53491-0.00031-6 · Cited by 315
Japanese Clinical Practice Guideline for Diabetes 2016
Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E. (2018) · Diabetology International · doi:10.1007/s13340-018-0345-3 · Cited by 319
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy
Spallone, V., Morganti, R., D’Amato, C., Greco, C., Cacciotti, L., & Marfia, G. A. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03500.x · Cited by 309
Self-citationDonaghue, K. C., Marcovecchio, M. L., Wadwa, R. P., Chew, E. Y., Wong, T. Y., Calliari, L. E., Zabeen, B., Salem, M. A., & Craig, M. E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12742 · Cited by 298
“perception of vibration and soft touch sensation (usually 10 g monofilaments), and evaluation of ankle and knee tendon reflexes.(113,116) Peripheral nerve lab tests include: quantitative vibration, thermal”
BackgroundGlucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials
Ang, L., Jaiswal, M., Martin, C., & Pop-Busui, R. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0528-7 · Cited by 303
Spallone, V. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0259 · Cited by 295
Self-citationDabbah, M. A., Graham, J., Petropoulos, I. N., Tavakoli, M., & Malik, R. A. (2011) · Medical Image Analysis · doi:10.1016/j.media.2011.05.016 · Cited by 293
“Unfortunately, diabetic neuropathy lacks a non-invasive surrogate for nerve damage (Tesfaye et al., 2010).”
BackgroundSelf-citationUpdates in diabetic peripheral neuropathy
Juster-Switlyk, K., & Smith, A. G. (2016) · F1000Research · doi:10.12688/f1000research.7898.1 · Cited by 288
Gain-of-function mutations in sodium channel NaV1.9 in painful neuropathy
Huang, J., Han, C., Estacion, M., Vasylyev, D., Hoeijmakers, J. G. J., Gerrits, M. M., Tyrrell, L., Lauria, G., Faber, C. G., Dib-Hajj, S. D., et al. (2014) · Brain · doi:10.1093/brain/awu079 · Cited by 288
“, 2012), in patients with a diagnosis of painful small fibre neuropathy according to the international criteria (Tesfaye et al., 2010; Hoeijmakers et al., 2012a).”
BackgroundSelf-citationTreatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes
Gibbons, C. H., & Freeman, R. (2015) · Brain · doi:10.1093/brain/awu307 · Cited by 282
“Autonomic symptoms and signs are common, prominent and appear acutely, in contrast to the relatively lower prevalence, gradual onset and slow progression in distal sensory-motor polyneuropathy (Tesfaye et al., 2010).”
BackgroundSelf-citationAkkus, G., & Sert, M. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i12.1106 · Cited by 228
Diabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 234
“42 Commonly affected nerves include the cranial nerves.”
InfluentialObesity and hyperlipidemia are risk factors for early diabetic neuropathy
Smith, A. G., & Singleton, J. R. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.04.003 · Cited by 272
“Peripheral neuropathy is the most common microvascular complication, affecting 50% (Tesfaye et al., 2010).”
InfluentialInflammation as a Therapeutic Target for Diabetic Neuropathies
Pop-Busui, R., Ang, L., Holmes, C., Gallagher, K., & Feldman, E. L. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0727-5 · Cited by 259
Peripheral neuropathy in prediabetes and the metabolic syndrome
Stino, A. M., & Smith, A. G. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12650 · Cited by 268
Jensen, T. S., Karlsson, P., Gylfadottir, S. S., Andersen, S. T., Bennett, D. L., Tankisi, H., Finnerup, N. B., Terkelsen, A. J., Khan, K., Themistocleous, A. C., et al. (2021) · Brain · doi:10.1093/brain/awab079 · Cited by 265
Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment
Serhiyenko, V. A., & Serhiyenko, A. A. (2018) · World Journal of Diabetes · doi:10.4239/wjd.v9.i1.1 · Cited by 251
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
Galiero, R., Caturano, A., Vetrano, E., Beccia, D., Brin, C., Alfano, M., Di Salvo, J., Epifani, R., Piacevole, A., Tagliaferri, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043554 · Cited by 225
“It is probable that signs and symptoms are present together, confirmed if symptoms and/or signs are associated with alterations in nerve conduction studies [62].”
BackgroundMethodRomán-Pintos, L. M., Villegas-Rivera, G., Rodríguez-Carrizalez, A. D., Miranda-Díaz, A. G., & Cardona-Muñoz, E. G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/3425617 · Cited by 248
“To assess the severity of DSPN, several approaches can be recommended: the graded approach outlined above, various continuous measures of sum scores of neurologic signs, symptoms or nerve test scores, and scores of function of acts of daily living or of predetermined tasks or of disability.”
BackgroundThe risk factors for diabetic peripheral neuropathy: A meta-analysis
Liu, X., Xu, Y., An, M., & Zeng, Q. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212574 · Cited by 242
Andersen, S. T., Witte, D. R., Dalsgaard, E.-M., Andersen, H., Nawroth, P., Fleming, T., Jensen, T. M., Finnerup, N. B., Jensen, T. S., Lauritzen, T., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2062 · Cited by 248
Chen, X., Graham, J., Dabbah, M. A., Petropoulos, I. N., Ponirakis, G., Asghar, O., Alam, U., Marshall, A., Fadavi, H., Ferdousi, M., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2422 · Cited by 245
Self-citationCardiac Autonomic Neuropathy in Diabetes Mellitus
Agashe, S., & Petak, S. (2018) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-14-4-251 · Cited by 239
Epidemiology of polyneuropathy in diabetes and prediabetes
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53480-4.00001-1 · Cited by 235
“DSPN is a symmetric, length-dependent sensorimotor polyneuropathy attributable to metabolic and microvessel alterations as a result of chronic hyperglycemia exposure and associated cardiovascular risk factors (Tesfaye et al., 2010).”
BackgroundSelf-citationDiagnostic criteria for small fibre neuropathy in clinical practice and research
Devigili, G., Rinaldo, S., Lombardi, R., Cazzato, D., Marchi, M., Salvi, E., Eleopra, R., & Lauria, G. (2019) · Brain · doi:10.1093/brain/awz333 · Cited by 234
“Therefore, when we compared the reliability of the Besta criteria for definite SFN against the NEURODIAB criteria used as the gold standard, all except one patient met the criteria.”
BackgroundMethodSelf-citationMouse Models of Diabetic Neuropathy
O'Brien, P. D., Sakowski, S. A., & Feldman, E. L. (2014) · ILAR Journal · doi:10.1093/ilar/ilt052 · Cited by 234
“Progression then involves dysfunction and degeneration of larger myelinated nerve fibers, resulting in a loss of ankle reflexes, sensory ataxia, and decreased proprioception (Tesfaye et al. 2010).”
Diabetic Neuropathy and Oxidative Stress: Therapeutic Perspectives
Hosseini, A., & Abdollahi, M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/168039 · Cited by 232
Peltier, A., Goutman, S. A., & Callaghan, B. C. (2014) · BMJ · doi:10.1136/bmj.g1799 · Cited by 218
Rapid Automated Diagnosis of Diabetic Peripheral Neuropathy With In Vivo Corneal Confocal Microscopy
Petropoulos, I. N., Alam, U., Fadavi, H., Marshall, A., Asghar, O., Dabbah, M. A., Chen, X., Graham, J., Ponirakis, G., Boulton, A. J. M., et al. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-13787 · Cited by 231
“4 years) were assessed for the presence and severity of DSPN between 2010 and 2011 based on the updated Toronto consensus criteria.(2) Informed written consent was obtained from all participants prior to their enrolment to the study.”
Self-citationSmall-fibre neuropathies—advances in diagnosis, pathophysiology and management
Hoeijmakers, J. G., Faber, C. G., Lauria, G., Merkies, I. S., & Waxman, S. G. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.97 · Cited by 228
Self-citationDiabetic Neuropathies: Diagnosis and Management
Deli, G., Bosnyak, E., Pusch, G., Komoly, S., & Feher, G. (2013) · Neuroendocrinology · doi:10.1159/000358728 · Cited by 226
Tesfaye, S., Sloan, G., Petrie, J., White, D., Bradburn, M., Julious, S., Rajbhandari, S., Sharma, S., Rayman, G., Gouni, R., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01472-6 · Cited by 213
Self-citationEmerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy
Bönhof, G. J., Herder, C., Strom, A., Papanas, N., Roden, M., & Ziegler, D. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00107 · Cited by 221
Reappraising neuropathic pain in humans—how symptoms help disclose mechanisms
Truini, A., Garcia-Larrea, L., & Cruccu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.180 · Cited by 226
Neuropathy in prediabetes: does the clock start ticking early?
Papanas, N., Vinik, A. I., & Ziegler, D. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.113 · Cited by 212
Self-citationRisk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015
Papanas, N., & Ziegler, D. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.48 · Cited by 207
“Moreover, DSPN is a pivotal risk factor for diabetic foot ulceration due to the loss of protective sensation [2, 4, 5].”
BackgroundInfluentialChronic Diabetes Complications: The Need to Move beyond Classical Concepts
Mauricio, D., Alonso, N., & Gratacòs, M. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.01.007 · Cited by 202
Ziegler, D., Tesfaye, S., Spallone, V., Gurieva, I., Al Kaabi, J., Mankovsky, B., Martinka, E., Radulian, G., Nguyen, K. T., Stirban, A. O., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109063 · Cited by 196
Self-citationDiagnostics and treatment of the diabetic foot
Apelqvist, J. (2012) · Endocrine · doi:10.1007/s12020-012-9619-x · Cited by 199
“The benefits of pharmacological treatment to improve perfusion remain controversial [2, 4].”
BackgroundEfficacy of α-lipoic acid in diabetic neuropathy
Papanas, N., & Ziegler, D. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.972935 · Cited by 194
“Typical neuropathic symptoms, notably pain, numbness, paraesthesiae, and dysaesthesiae with a length-dependent stocking-and-glove distribution, often deteriorating at night, may be encountered in ~ 20% of all diabetic patients [2,5,6].”
BackgroundMethodInfluentialA new look at painful diabetic neuropathy
Sloan, G., Shillo, P., Selvarajah, D., Wu, J., Wilkinson, I. D., Tracey, I., Anand, P., & Tesfaye, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.08.020 · Cited by 189
Self-citationAdvances in Screening, Early Diagnosis and Accurate Staging of Diabetic Neuropathy
Carmichael, J., Fadavi, H., Ishibashi, F., Shore, A. C., & Tavakoli, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.671257 · Cited by 176
“In 2010, the Toronto Consensus, by an expert panel recommended that one abnormal fi nding as part of NCS, combined with a symptom or sign of neuropathy should be used to con fi rm DPN (41).”
BackgroundAutonomic Neuropathy in Diabetes Mellitus
Verrotti, A., Prezioso, G., Scattoni, R., & Chiarelli, F. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00205 · Cited by 187
“The prevalence of organic sexual dysfunction is also high with erectile dysfunction (35–90%) and retrograde ejaculation (32%) (5, 30).”
BackgroundInfluentialPainful and Painless Diabetic Neuropathies: What Is the Difference?
Shillo, P., Sloan, G., Greig, M., Hunt, L., Selvarajah, D., Elliott, J., Gandhi, R., Wilkinson, I. D., & Tesfaye, S. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1150-5 · Cited by 183
Self-citationUnderstanding Diabetic Neuropathy: Focus on Oxidative Stress
Pang, L., Lian, X., Liu, H., Zhang, Y., Li, Q., Cai, Y., Ma, H., & Yu, X. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9524635 · Cited by 184
“Collectively, it suggests that hyperglycaemia is not the prime driving cause of all complications [35, 65], and mechanisms underlying diabetic neuropathy in type I and type II diabetes could be fundamentally different [47].”
BackgroundPrevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis
Sun, J., Wang, Y., Zhang, X., Zhu, S., & He, H. (2020) · Primary Care Diabetes · doi:10.1016/j.pcd.2019.12.005 · Cited by 166
Japanese Clinical Practice Guideline for Diabetes 2016
Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12810 · Cited by 181
Cardiovascular autonomic neuropathies as complications of diabetes mellitus
Kuehl, M., & Stevens, M. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.21 · Cited by 181
Retinal Vascular Caliber as a Biomarker for Diabetes Microvascular Complications
Ikram, M. K., Cheung, C. Y., Lorenzi, M., Klein, R., Jones, T. L. Z., Wong, T. Y., & for the NIH/JDRF Workshop on Retinal Biomarker for Diabetes Group (2013) · Diabetes Care · doi:10.2337/dc12-1554 · Cited by 180
Microvascular and macrovascular complications in children and adolescents
Donaghue, K. C., Wadwa, R. P., Dimeglio, L. A., Wong, T. Y., Chiarelli, F., Marcovecchio, M. L., Salem, M., Raza, J., Hofman, P. L., & Craig, M. E. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12180 · Cited by 181
“The somatic neuropathies associated with diabetes fall into two broad categories: focal/multifocal and generalized (90).”
Selvarajah, D., Cash, T., Davies, J., Sankar, A., Rao, G., Grieg, M., Pallai, S., Gandhi, R., Wilkinson, I. D., & Tesfaye, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138224 · Cited by 178
Self-citationRepeatability of In Vivo Corneal Confocal Microscopy to Quantify Corneal Nerve Morphology
Petropoulos, I. N., Manzoor, T., Morgan, P., Fadavi, H., Asghar, O., Alam, U., Ponirakis, G., Dabbah, M. A., Chen, X., Graham, J., et al. (2013) · Cornea · doi:10.1097/ico.0b013e3182749419 · Cited by 180
Self-citationPetropoulos, I. N., Alam, U., Fadavi, H., Asghar, O., Green, P., Ponirakis, G., Marshall, A., Boulton, A. J. M., Tavakoli, M., & Malik, R. A. (2013) · Diabetes Care · doi:10.2337/dc13-0193 · Cited by 179
Self-citationDidangelos, T., Karlafti, E., Kotzakioulafi, E., Margariti, E., Giannoulaki, P., Batanis, G., Tesfaye, S., & Kantartzis, K. (2021) · Nutrients · doi:10.3390/nu13020395 · Cited by 163
“…more cardiovascular autonomic reflex tests (CARTs) were abnormal for DAN and when abnormal nerve conduction velocity levels with abnormal Michigan Neuropathy Screening Instrument Questionnaire (MNSIQ) and Michigan Neuropathy Screening Instrument Examination (MNSIE) were present for DPN [4,5,40,41].”
BackgroundMethodSelf-citationAn Automatic Tool for Quantification of Nerve Fibers in Corneal Confocal Microscopy Images
Chen, X., Graham, J., Dabbah, M. A., Petropoulos, I. N., Tavakoli, M., & Malik, R. A. (2017) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2573642 · Cited by 171
Self-citationAlam, U., Jeziorska, M., Petropoulos, I. N., Asghar, O., Fadavi, H., Ponirakis, G., Marshall, A., Tavakoli, M., Boulton, A. J. M., Efron, N., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0180175 · Cited by 170
Self-citationRaputova, J., Srotova, I., Vlckova, E., Sommer, C., Üçeyler, N., Birklein, F., Rittner, H. L., Rebhorn, C., Adamova, B., Kovalova, I., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000001034 · Cited by 169
Diabetic neuropathy: what does the future hold?
Callaghan, B. C., Gallagher, G., Fridman, V., & Feldman, E. L. (2020) · Diabetologia · doi:10.1007/s00125-020-05085-9 · Cited by 158
“The most disabling symptom of neuropathy is often neuropathic pain, which is experienced by about a quarter of individuals with the disorder [23, 32].”
BackgroundDiabetic Neuropathy and Gait: A Review
Alam, U., Riley, D. R., Jugdey, R. S., Azmi, S., Rajbhandari, S., D’Août, K., & Malik, R. A. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0295-y · Cited by 165
“The occurrence of other diabetic microvascular complications in a given patient strengthens the case that DPN is attributable to diabetes [1].”
BackgroundSelf-citationBiessels, G. J., Bril, V., Calcutt, N. A., Cameron, N. E., Cotter, M. A., Dobrowsky, R., Feldman, E. L., Fernyhough, P., Jakobsen, J., Malik, R. A., et al. (2014) · Journal of the Peripheral Nervous System · doi:10.1111/jns5.12072 · Cited by 165
“Electrophysiological assessment of nerve function in diabetic patients provides a quantitative measure of nerve integrity and a means to monitor disease onset and progression (Tesfaye et al., 2010).”
BackgroundInfluentialSelf-citationPop-Busui, R., Lu, J., Brooks, M. M., Albert, S., Althouse, A. D., Escobedo, J., Green, J., Palumbo, P., Perkins, B. A., Whitehouse, F., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0012 · Cited by 167
Chronic Pain with Neuropathic Characteristics in Diabetic Patients: A French Cross-Sectional Study
Bouhassira, D., Letanoux, M., & Hartemann, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074195 · Cited by 170
“The use of standardized clinical examination, such as the MNSIexamination and monofilament test, also result in the underdiagnosis of diabetic polyneuropathy because these tests do not assess the functionality of small nerve fibers which can be preferentially or selectively injured in diabetic patients, especially in…”
BackgroundMethodMayeda, L., Katz, R., Ahmad, I., Bansal, N., Batacchi, Z., Hirsch, I. B., Robinson, N., Trence, D. L., Zelnick, L., & de Boer, I. H. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000991 · Cited by 162
Metadata
- Authors
- Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., Bernardi, L., Valensi, P., & on behalf of the Toronto Diabetic Neuropathy Expert Group
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Mayo Clinic (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Adelaide (AU)
- I Department of Medicine, Semmelweis University, Budapest, Hungary;
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Rome Tor Vergata (IT)
- Eastern Virginia Medical School (US)
- University of Pavia (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tesfaye, Solomon
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-01
- Volume
- 33
- Issue
- 10
- Pages
- 2285-2293
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2945176
- OpenAlex
- W2113384757
- Cited by
- 2,690
- References
- 77
- Citations by year
- 2026: 180 · 2025: 190 · 2024: 221 · 2023: 199 · 2022: 226 · 2021: 235 · 2020: 220 · 2019: 175 · 2018: 189 · 2017: 155 · 2016: 157 · 2015: 127 · 2014: 151 · 2013: 102 · 2012: 94
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by-nc-nd)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Eli Lilly and Company
- Louisiana State University
- Eastern Virginia Medical School
- Semmelweis Egyetem
- Gentofte Hospital
- University of Toronto
- Odense Universitetshospital
- Szegedi Tudományegyetem
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- diabetic neuropathy, diabetic peripheral neuropathy, diabetic autonomic neuropathy, diabetic neuropathic pain, neuropathy classification, diagnostic criteria, neuropathy treatment
- MeSH terms
- Diabetic Neuropathies, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.